Gregianin L - Search Results

1

Targeting the epigenome of cancer stem cells in pediatric nervous system tumors.

Freire NH, Jaeger MDC, de Farias CB, Nör C, Souza BK, Gregianin L, Brunetto AT, Roesler R. Freire NH, et al. Among authors: gregianin l. Mol Cell Biochem. 2023 Oct;478(10):2241-2255. doi: 10.1007/s11010-022-04655-2. Epub 2023 Jan 13. Mol Cell Biochem. 2023. PMID: 36637615 Review.

2

Nutritional status of adolescents with hematological malignancies, bone tumors, and other solid tumors during the first year after diagnosis.

Dalle Molle R, da Cruz LB, Gregianin LJ, Brunetto AL. Dalle Molle R, et al. Pediatr Blood Cancer. 2013 Jan;60(1):165. doi: 10.1002/pbc.24306. Epub 2012 Sep 21. Pediatr Blood Cancer. 2013. PMID: 23002025 No abstract available.

3

Omission of doxorubicin from the treatment of stage II-III, intermediate-risk Wilms' tumour (SIOP WT 2001): an open-label, non-inferiority, randomised controlled trial.

Pritchard-Jones K, Bergeron C, de Camargo B, van den Heuvel-Eibrink MM, Acha T, Godzinski J, Oldenburger F, Boccon-Gibod L, Leuschner I, Vujanic G, Sandstedt B, de Kraker J, van Tinteren H, Graf N; SIOP Renal Tumours Study Group. Pritchard-Jones K, et al. Lancet. 2015 Sep 19;386(9999):1156-64. doi: 10.1016/S0140-6736(14)62395-3. Epub 2015 Jul 9. Lancet. 2015. PMID: 26164096 Free article. Clinical Trial.

4

Autologous hematopoietic stem cell transplantation in children with relapse or refractory Hodgkin disease.

Galvão de Castro C Jr, Gregianin LJ, Brunetto AL. Galvão de Castro C Jr, et al. J Pediatr Hematol Oncol. 2006 Nov;28(11):772. doi: 10.1097/01.mph.0000243655.18314.88. J Pediatr Hematol Oncol. 2006. PMID: 17114969 No abstract available.

5

Highlights from the 1st Latin American meeting on metronomic chemotherapy and drug repositioning in oncology, 27-28 May, 2016, Rosario, Argentina.

Rosé A, André N, Rozados VR, Mainetti LE, Menacho Márquez M, Rico MJ, Schaiquevich P, Villarroel M, Gregianin L, Graupera JM, García WG, Epelman S, Alasino C, Alonso D, Chantada G, Scharovsky OG. Rosé A, et al. Among authors: gregianin l. Ecancermedicalscience. 2016 Sep 6;10:672. doi: 10.3332/ecancer.2016.672. eCollection 2016. Ecancermedicalscience. 2016. PMID: 27610198 Free PMC article.

6

The use of high-frequency audiometry increases the diagnosis of asymptomatic hearing loss in pediatric patients treated with cisplatin-based chemotherapy.

Abujamra AL, Escosteguy JR, Dall'Igna C, Manica D, Cigana LF, Coradini P, Brunetto A, Gregianin LJ. Abujamra AL, et al. Pediatr Blood Cancer. 2013 Mar;60(3):474-8. doi: 10.1002/pbc.24236. Epub 2012 Jun 28. Pediatr Blood Cancer. 2013. PMID: 22744939

7

Viability of D283 medulloblastoma cells treated with a histone deacetylase inhibitor combined with bombesin receptor antagonists.

Jaeger M, Ghisleni EC, Fratini L, Brunetto AL, Gregianin LJ, Brunetto AT, Schwartsmann G, de Farias CB, Roesler R. Jaeger M, et al. Among authors: gregianin lj. Childs Nerv Syst. 2016 Jan;32(1):61-4. doi: 10.1007/s00381-015-2963-4. Epub 2015 Nov 20. Childs Nerv Syst. 2016. PMID: 26590027

8

BDNF/TrkB Signaling as a Potential Novel Target in Pediatric Brain Tumors: Anticancer Activity of Selective TrkB Inhibition in Medulloblastoma Cells.

Thomaz A, Jaeger M, Buendia M, Bambini-Junior V, Gregianin LJ, Brunetto AL, Brunetto AT, de Farias CB, Roesler R. Thomaz A, et al. J Mol Neurosci. 2016 Jul;59(3):326-33. doi: 10.1007/s12031-015-0689-0. Epub 2015 Nov 27. J Mol Neurosci. 2016. PMID: 26614346

9

Trk inhibition reduces cell proliferation and potentiates the effects of chemotherapeutic agents in Ewing sarcoma.

Heinen TE, Dos Santos RP, da Rocha A, Dos Santos MP, Lopez PL, Silva Filho MA, Souza BK, Rivero LF, Becker RG, Gregianin LJ, Brunetto AL, Brunetto AT, de Farias CB, Roesler R. Heinen TE, et al. Oncotarget. 2016 Jun 7;7(23):34860-80. doi: 10.18632/oncotarget.8992. Oncotarget. 2016. PMID: 27145455 Free PMC article.

10

Low brain-derived neurotrophic factor levels are associated with active disease and poor prognosis in childhood acute leukemia.

Portich JP, Gil MS, Dos Santos RP, Goulart BK, Ferreira MB, Loss JF, Gregianin LJ, Brunetto AL, Brunetto AT, Roesler R, de Farias CB. Portich JP, et al. Cancer Biomark. 2016 Sep 26;17(3):347-352. doi: 10.3233/CBM-160646. Cancer Biomark. 2016. PMID: 27434294

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

52 results

Search Page

Filters